Philip J. Barter - Concepedia

Author

Philip J. Barter

Also Known As

A Maggioni, Barter, P., Barter, Philip John, Beverley Balkau, C Baigent, David R. Sullivan, Gerd Assmann, Hidenori Arai, J. Fruchart, Khalid Al Rasadi

552

Publications

55.6K

Citations

H-Index

152

Concepts

All Affiliations

The Heart Research Institute UNSW Sydney The University of Sydney Flinders University The University of Adelaide

About

Philip J. Barter is an author at The Heart Research Institute specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	131	12.2K
2	Health Sciences	29	38	1.8K
3	Public Health	22	26	5.2K
4	Natural Sciences	7	7	266
5	Engineering	6	6	234

Philip J. Barter

259

Publications

37.5K

Citations

H-Index

Page 1

	Year	Citations
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease John C. LaRosa, Scott M. Grundy, David D. Waters, New England Journal of Medicine	2005	3.5K
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial A Keech, R. John Simes, Philip J. Barter, The Lancet Diabetes ManagementCardiovascular DiseaseHealth PolicyLong-term Fenofibrate TherapyDiabetes	2005	3.2K
Effects of Torcetrapib in Patients at High Risk for Coronary Events Philip J. Barter, Mark J. Caulfield, Mats Eriksson, New England Journal of Medicine	2007	3.1K
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome Gregory G. Schwartz, Anders Olsson, Markus Abt, New England Journal of Medicine	2012	2K
HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events Philip J. Barter, Antonio M. Gotto, John C. LaRosa, New England Journal of Medicine	2007	1.6K
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia, JAMA	2020	911
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease Stephen J. Nicholls, Christie M. Ballantyne, Philip J. Barter, New England Journal of Medicine	2011	877
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules Gillian Cockerill, Kerry‐Anne Rye, Jennifer R. Gamble, Arteriosclerosis Thrombosis and Vascular Biology Vascular DiseaseCell AdhesionImmunologyPathologyP75 Subunits	1995	773
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer, New England Journal of Medicine	2017	768
Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease Christopher P. Cannon, Sukrut Shah, Hayes M. Dansky, New England Journal of Medicine	2010	746

Page 1